Does the triglyceride-glucose index predict 1-year major adverse cardiovascular events in end-stage renal disease patients with coronary artery disease?
The TyG index may enhance risk categorization for MACE in patients with ESRD and CAD.
The TyG index might serve as a valuable and dependable indicator of MACE risk in individuals with dialysis and CAD, indicating its potential significance in enhancing risk categorization in clinical settings.
Xie et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: